Omnicell

IPO

Omnicell is a healthcare company in Mountain View, United States, founded in 1992. It has raised $20.0M across 2 rounds, most recently a $20.0M Series B in February 1999.

Defining. Delivering. Outcomes.

Employees
1001–5000
Founded
1992
Business Model
B2B
Total Funding
$20.0M
Last Round
$20.0M Series BFeb 1999
Rounds
2
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Omnicell provides an intelligent pharmacy and medication management infrastructure combining robotics, smart devices, software analytics, and expert services. Their solutions span inpatient and outpatient care settings, enabling pharmacists and care teams to shift from manual medication processes to autonomous pharmacy operations. The flagship Titan XT automated dispensing system reduces human error, improves workflow efficiency, and provides real-time supply chain visibility. Through their Autonomous Pharmacy vision, Omnicell converts operational data into actionable insights that maximize safety, efficiency, and clinical outcomes while ensuring regulatory compliance.

Summary

It lists 1001–5000 employees. It has raised $20.0M in total across 2 rounds, most recently a $20.0M Series B round in Feb 1999. Investors include ABS Capital Partners, Sutter Hill and Sequoia Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
IPOAug 2001
$42.0M

Sign up to see all 3 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Zipline

Zipline operates an autonomous delivery service that transports medical supplies, food, and retai...

South San Francisco, United States501–1000Climate Tech, Defense Tech
Series G+Total funding$2.0BMar 2026
Galbot

Builds embodied multimodal large-model humanoid robots and robotic systems for retail, manufactur...

Beijing, China51–200Artificial Intelligence, Robotics
Series CTotal funding$1.2BMar 2026
CMR Surgical

CMR Surgical develops Versius Plus, a surgical robot engineered for versatility and adaptability ...

Cambridge, United Kingdom501–1000Healthcare, Robotics
Venture RoundTotal funding$1.2BApr 2025
Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Omnicell on Indexed.vc
<a href="https://indexed.vc/companies/omnicell"><img src="https://indexed.vc/api/badge/company/omnicell" alt="Omnicell on Indexed.vc" width="260" height="76" /></a>